日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeutics

目前利用临床前模型评估基于人腺病毒的癌症疗法

Cole, David K; Khanolkar, Rahul C; Davies, James A; Gerry, Andrew B

Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer

Tebentafusp 是一种 T 细胞衔接剂,可促进巨噬细胞重编程,并与 IL-2 联合使用可克服癌症中的巨噬细胞免疫抑制。

Güç, Esra; Treveil, Agatha; Leach, Emma; Broomfield, Anna; Camera, Antonio; Clubley, James; Nieto Garcia, Paula; Kazachenka, Anastasiya; Khanolkar, Rahul; Del Carpio, Luis; Heyn, Holger; Hassel, Jessica C; Sacco, Joseph J; Stanhope, Sarah; Collins, Laura; Piulats, Josep M; Ranade, Koustubh; Benlahrech, Adel

Molecular basis underpinning MR1 allomorph recognition by an MR1-restricted T cell receptor

MR1限制性T细胞受体识别MR1同种异形体的分子基础

Suckling, Richard J; Pamukcu, Cevriye; Simmons, Robert Alan; Fonseca, Daniel; Grant, Emma; Harrison, Rory; Shaikh, Saher A; Khanolkar, Rahul C; Ghadbane, Hemza; Creese, Andrew; Hock, Miriam; Gligoris, Thomas G; Lepore, Marco; Karuppiah, Vijaykumar; Salio, Mariolina

A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c(+) cells.

CD1c 脂质非依赖性 T 细胞受体双特异性衔接器可将 T 细胞重新定向攻击 CD1c(+) 细胞

Szoke-Kovacs Rita, Khakoo Sophie, Rangel Victor Lopes, Della Cristina Pietro, Pentier Johanne, Khanolkar Rahul, El-Ajouz Sam, Simmons Robert, Cole David K, Gogolak Peter, Salio Mariolina, Karuppiah Vijaykumar

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus

免疫调节性可溶性CTLA-4可改变系统性红斑狼疮中的效应T细胞反应

Dahal, Lekh N; Basu, Neil; Youssef, Hazem; Khanolkar, Rahul C; Barker, Robert N; Erwig, Lars P; Ward, Frank J